Tactile Systems Technology, Inc. Company Profile & Data: stocks, market cap, financials, digital and more

                        
Company
Tactile Systems Technology, Inc.Headquarters: Minneapolis, 
                        MN, United States
                    
Employees: 988
CEO: Mr. Daniel L. Reuvers

                                    NASDAQ: TCMD
                                
                                            +1.85%
                                            
Market Cap$417.3 Million

                        USD as of Jan. 1, 2025
                    
                            Market Cap History

Tactile Systems Technology, Inc. Categories

United States Healthcare Medical Devices
United States Healthcare United States Medical Devices

Tactile Systems Technology, Inc. market capitalization over time

Evolution of Tactile Systems Technology, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Tactile Systems Technology, Inc.

Top Competitors by Market Capitalization

Industry: Medical Devices

Company	Market Cap (USD)
Abbott	$213.72 B
Stryker	$150.01 B
Boston Scientific Corporation	$149.80 B
Medtronic	$114.44 B
Shenzhen Mindray Bio-Medical Electronics Co. Ltd	$47.37 B

Sector:

Company	Market Cap (USD)
Lilly	$689.42 B
Novo Nordisk	$622.07 B
UnitedHealth Group	$487.54 B
Johnson & Johnson	$353.05 B
AbbVie	$301.60 B

Detailed Description

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date	Dec. 31, 2023
Revenue TTM	$274.4 M
EBITDA	$24.5 M
Gross Profit TTM	$195.1 M
Profit Margin	10.39%
Operating Margin	15.20%
Quarterly Revenue Growth	5.10%